Most Read News

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

Aurobindo Pharma announced that its wholly owned subsidiary company Eugia Pharma Specialties has received a final approval from the US Food Drug Administration USFDA to manufacture and market Vasopressin Injection USP 20 UnitsmL Multiple-Dose Vials Vasopressin Injection USP 20 UnitsmL Multiple-Dose Vials to be bioequivalent and therapeutically equivalent to the reference listed drug RLD Vasostrict Injection 20 unitsmL of Par Sterile Products LLC Par The […]

image

Promax Power will hold a meeting of the Board of Directors of the Company on 24 August 2022

image

Betex India will hold a meeting of the Board of Directors of the Company on 25 August 2022

image

Vishal Bearings will hold a meeting of the Board of Directors of the Company on 29 August 2022

image

Grovy India announced that the 37th Annual General Meeting AGM of the company will be held on 9 September 2022

image

Contil India announced that the Annual General Meeting AGM of the company will be held on 24 September 2022

image

Sailani Tours N Travels announced that the 3rd Annual General Meeting AGM of the company will be held on 5 September 2022

image

Radhika Jeweltech will hold a meeting of the Board of Directors of the Company on 22 August 2022

image

Kennametal India announced that the 57th Annual General Meeting AGM of the company will be held on 11 November 2022

image

MPL Plastics announced that the 30th Annual General Meeting AGM of the company will be held on 26 September 2022

Image
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.